LGLijia Guo

Lijia Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lijia Guo has a total of 38 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Liu

    Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China

    8 shared publications
  • Junji Xu

    Department of Periodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, China

    7 shared publications
  • Yao Jiao

    Department of Stomatology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

    7 shared publications
  • Xiaoyan Li

    Laboratory of Tissue Regeneration and Immunology, Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China

    6 shared publications
  • Yitong Liu

    Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China

    5 shared publications
  • Juan Du

    Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China

    4 shared publications

Latest Publications

  • Open Access

    TLR9-engineered photoresponsive biomimetic nanodecoys for targeted NETs clearance to mitigate periodontitis-associated bone resorption

    by Siyan Liu, Yitong Liu, Yingyi Chen, Yao Jiao, Rui Zhao, Yijia Wang, Jiebing Zhang, Shuang Zhang, Yi Liu, Lijia Guo


  • Microbial changes in different parts of the oral cavity during the early stage of clear aligner treatment: a preliminary study

    by Yao Jiao, Yan Xu, Yitong Liu, Xiaoyan Li, Xue Li, Siyan Liu, Yi Liu, Yanan Hou, Lijia Guo

    Objectives More and more patients choose clear aligners to improve their appearance and masticatory function. However, there is no study on whether clear aligner treatment affects the microecology of oral mucosal plaque. Therefore, we analyzed flora changes in different parts of patients’ mucosa at various time points during the early stage of clear aligner treatment. Methods Plaque samples were collected from the buccal, palatal, and dorsal lingual mucosa of 10 subjects before and 1, 3, 6, and 12 months post clear orthodontic treatment. Microbial community changes were analyzed by 16 S rRNA gene sequencing. Results At 6 months, buccal plaque showed a significant decrease in alpha diversity and distinct microbial separation. By 12 months, diversity had recovered, and the community structure had returned to baseline levels. Genus-level changes varied by site: the periodontal pathogen Fusobacterium increased at 6 months and declined at 12 months; the periodontally relevant Prevotella showed a temporary increase at 3 months (palatal) and 1 month (dorsal lingual). Conclusions The clear aligner altered the microbial community of buccal mucosal plaque by 6 months, and the microbial community returned to the basal composition by 12 months. Clinical relevance This study highlights that clear aligner treatment transiently disrupts the oral mucosal microbiome, with a significant but reversible shift toward periodontal pathogen-associated flora within 6 months, suggesting the need for enhanced oral hygiene monitoring during early orthodontic therapy to mitigate potential periodontal risks.


  • Cortical perforation promotes bone regeneration by enhancing nerve growth factor secretion

    by Yao Jiao, Yitong Liu, Xiaoyan Li, Nannan Han, Siyan Liu, Juan Du, Junji Xu, Song Li, Lijia Guo, Yi Liu


  • Open Access

    Periodontally accelerated osteogenic orthodontics adjuvant camouflage therapy for Class III malocclusion: a case report

    by Yao Jiao, Yitong Liu, Xiaoyan Li, Song Li, Junji Xu, Yi Liu, Lijia Guo

    Orthodontic treatment carries potential risks and complications, especially if the path of tooth movement extends beyond the alveolar bone or if the patient has a thin bone plate. This amplifies the patient’s risk of complications such as bone fenestration and bone dehiscence. Hence, orthodontists should consider the patient’s periodontal and dental condition during treatment and opt for a multidisciplinary approach when necessary to achieve optimal results. This case report describes a successfully treated case of Class III malocclusion using an adjuvant therapy known as periodontally accelerated osteogenic orthodontics (PAOO). A 25-year-old man sought treatment primarily due to an evident anterior negative overjet. The patient was diagnosed with a skeletal Class III relationship and mandibular prognathism. A clinical examination revealed a severe Class III molar relationship and an anterior negative overjet. Moreover, cone-beam computed tomography revealed a thin labial bone plate in relation to the mandibular anterior teeth. The molar relation was corrected through molar distalization using miniscrews, and the mandibular incisors were retracted in conjunction with the PAOO procedure. Post-treatment outcomes demonstrated improved occlusal relationship, thickened labial bone plate of the mandibular anterior teeth, and absence of bone fenestration or dehiscence. This clinical case shows that orthodontic treatment requires a multidisciplinary approach. The favorable results indicate that PAOO is effective in maintaining alveolar bone thickness and reducing the risk of periodontal complications.


  • Open Access

    Fructose Potentiates Bone Loss and Marrow Adipose Tissue Accumulation by Inhibiting Adenosine 5ʹ-Monophosphate-Activated Protein Kinase in Mesenchymal Stem Cells

    by Ziqi Yan, Juan Du, Rui Zhao, Xu Liu, Junji Xu, Lijia Guo, Yi Liu

    Increased fructose consumption has been elucidated to contribute to metabolic diseases. Bone is a dynamic organ that undergoes constant remodeling. However, the effects of fructose on bone health are still in dispute. Here, we identified fructose deteriorated bone mineral density while promoting the abundance of bone marrow adipose tissue. Fructose remarkably promoted the bone marrow mesenchymal stem cells’ (BMMSCs) adipogenic commitment at the expense of osteogenic commitment. Fructose boosted the glycolysis of BMMSCs and inhibited phosphorylation of adenosine 5ʹ-monophosphate-activated protein kinase (AMPK), which played a crucial role in bone-fat alteration. Our results suggested that fructose potentiated bone loss and marrow adipose tissue accumulation by suppressing AMPK activation in BMMSCs. Understanding fructose which affected bone metabolism was thus of primary importance in order to establish preventative measures or treatments for this condition.


  • Open Access

    MicroRNA-155 targets SOCS1 to inhibit osteoclast differentiation during orthodontic tooth movement

    by Yao Jiao, Sicong Mi, Xiaoyan Li, Yitong Liu, Nannan Han, Junji Xu, Yi Liu, Song Li, Lijia Guo

    Background: MicroRNA-155 (miR-155) is a multifunctional miRNA whose expression is known to be involved in a range of physiological and pathological processes. Its association with several oral diseases has been established. However, the specific role of miR-155 in orthodontic tooth movement remains unclear. In this study, we investigated the impact of miR-155 on osteoclast differentiation and orthodontic tooth movement models, aiming to explore the underlying mechanisms. Methods: In this experiment, we utilized various agents including miR-155 mimic, miR-155 inhibitor, as well as non-specific sequences (NC mimic & NC inhibitor) to treat murine BMMNCs. Subsequently, osteoclast induction (OC) was carried out to examine the changes in the differentiation ability of monocytes under different conditions. To assess these changes, we employed RT-PCR, Western blotting, and TRAP staining techniques. For the orthodontic tooth movement model in mice, the subjects were divided into two groups: the NaCl group (injected with saline solution) and the miR-155 inhibitor group (injected with AntagomiR-155). We observed the impact of orthodontic tooth movement using stereoscopic microscopy, micro-CT, and HE staining. Furthermore, we performed RT-PCR and Western blotting analyses on the tissues surrounding the moving teeth. Additionally, we employed TargetScan to predict potential target genes of miR-155. Results: During osteoclast induction of BMMNCs, the expression of miR-155 exhibited an inverse correlation with osteoclast-related markers. Overexpression of miR-155 led to a decrease in osteoclast-related indexes, whereas underexpression of miR-155 increased those indexes. In the mouse orthodontic tooth movement model, the rate of tooth movement was enhanced following injection of the miR-155 inhibitor, leading to heightened osteoclast activity. TargetScan analysis identified SOCS1 as a target gene of miR-155. Conclusions: Our results suggest that miR-155 functions as an inhibitor of osteoclast differentiation, and it appears to regulate osteoclasts during orthodontic tooth movement. The regulatory mechanism of miR-155 in this process involves the targeting of SOCS1.


  • Open Access

    Mesenchymal stem cell-derived apoptotic bodies alleviate alveolar bone destruction by regulating osteoclast differentiation and function

    by Xiaoyan Li, Yiyang Jiang, Xu Liu, Jingfei Fu, Juan Du, Zhenhua Luo, Junji Xu, Ujjal Kumar Bhawal, Yi Liu, Lijia Guo

    Periodontitis is caused by overactive osteoclast activity that results in the loss of periodontal supporting tissue and mesenchymal stem cells (MSCs) are essential for periodontal regeneration. However, the hypoxic periodontal microenvironment during periodontitis induces the apoptosis of MSCs. Apoptotic bodies (ABs) are the major product of apoptotic cells and have been attracting increased attention as potential mediators for periodontitis treatment, thus we investigated the effects of ABs derived from MSCs on periodontitis. MSCs were derived from bone marrows of mice and were cultured under hypoxic conditions for 72 h, after which ABs were isolated from the culture supernatant using a multi-filtration system. The results demonstrate that ABs derived from MSCs inhibited osteoclast differentiation and alveolar bone resorption. miRNA array analysis showed that miR-223-3p is highly enriched in those ABs and is critical for their therapeutic effects. Targetscan and luciferase activity results confirmed that Itgb1 is targeted by miR-223-3p, which interferes with the function of osteoclasts. Additionally, DC-STAMP is a key regulator that mediates membrane infusion. ABs and pre-osteoclasts expressed high levels of DC-STAMP on their membranes, which mediates the engulfment of ABs by pre-osteoclasts. ABs with knock-down of DC-STAMP failed to be engulfed by pre-osteoclasts. Collectively, MSC-derived ABs are targeted to be engulfed by pre-osteoclasts via DC-STAMP, which rescued alveolar bone loss by transferring miR-223-3p to osteoclasts, which in turn led to the attenuation of their differentiation and bone resorption. These results suggest that MSC-derived ABs are promising therapeutic agents for the treatment of periodontitis.


  • Open Access

    Mesenchymal stem cell-derived apoptotic bodies alleviate alveolar bone destruction by regulating osteoclast differentiation and function

    by Yi Liu, Xiaoyan Li, Yiyang Jiang, Liu Xu, Jingfei Fu, Juan Du, Zhenhua Luo, Junji Xu, Ujjal Bhawal, Lijia Guo

    Periodontitis is caused by an imbalance between bone formation and resorption that results in the loss of periodontal supporting tissue. Mesenchymal stem cells (MSCs) are essential for the periodontal regeneration. However, the hypoxic periodontal microenvironment will induce the MSCs apoptosis. Apoptotic bodies (ABs) are the major product of apoptotic cells and are gaining increased attention as potential mediators for periodontitis treatment, thus we investigated the effects of ABs from MSCs on periodontitis. Bone marrow mesenchymal stem cells (BMMSCs) were cultured under hypoxia for 72 h to simulate the periodontal hypoxic microenvironment, after which ABs were isolated using a multi-filtration system from the supernatant of BMMSCs. Transmission electron microscopy, diameter assessment and immunofluorescence were used to characterize ABs. We found that ABs inhibited osteoclast differentiation and alveolar bone resorption, miR-223-3p is highly enriched in ABs and critical for the therapeutic effects of ABs. Targetscan and luciferase activity results confirmed that ITGB1 was targeted by miR-223-3p, which interfered the function of osteoclasts. Additionally, DC-STAMP is one of the key regulators that mediates membrane infusion. ABs and pre-osteoclasts are highly expressed DC-STAMP on the membrane, which mediated the target engulf of ABs by pre-osteoclasts. ABs with knock-down of DC-STAMP (KO-ABs) failed to be engulfed by pre-osteoclasts. Collectively, BMMSC-derived ABs can be targeted engulfed by pre-osteoclast via DC-STAMP, rescued alveolar bone loss by transferring miR-223-3p to osteoclasts, which led to the attenuation of their differentiation and bone resorption. These results suggest that MSCs derived ABs are promising therapeutic agents for the treatment of periodontitis.